Board of Directors

Associate Professor Rob Phillips

Rob Phillips is the inventor and founder of Uscom Limited and took the Company to public listing in 2003. Rob has more than 13yrs experience as Chairman and CEO of an ASX listed Medical Technology Company. Rob has successfully engineered the acquisition and integration of two international medical device companies in the last three years.

Associate Professor Rob Phillips has a Doctor of Philosophy and a Master of Philosophy from the School of Medicine at The University of Queensland, Australia. Rob conceived and developed the USCOM 1A device and is the author of over 30 patents in cardiovascular monitoring and ultrasound. Rob was a recipient of an Australian Post Graduate Award, and a finalist in the CNN, Google, Time, Science, NYSE World Technology Awards in Health and Medicine and is an adjunct Associate Professor at the University of Queensland.

 

Sheena Jack

Ms Sheena Jack is the Chief Executive Officer of HCF and has 27 years experience as a finance professional and corporate executive.

Sheena has had experience across a range of corporate organizations including ASX listed, Government and not for profit and in both mature and start up businesses. Sheena has significant experience in mergers and acquisitions, business integration, strategy development and implementation, capital markets and organizational transformation.

Sheena is a Chartered Accountant and a graduate member of the Australian Institute of Company Directors.

 

Christian Bernecker

Mr Christian Bernecker has experience as a Corporate Executive and Non Executive Director with a background of capital management and investment across a range of companies including life sciences in listed and unlisted entities.

Christian is a member of the Institute of Chartered Accountants and holds a Bachelor of Commerce degree.

 

Chao Xian (David) He

Mr He was born in Shanghai and educated in Sydney. For the last 9 years He was based in Shanghai and Singapore as Vice President of Business Development APAC with Johnson & Johnson. Prior to that David was an Associate at McKinsey & Company in Shanghai, then Director of Business Development and External Growth APAC and VP Finance China with AB InBev. Based in Hong Kong and Shanghai.

Mr He’s achievements include developing market strategy and building the acquisition pipeline for J&J consumer products and leading a number of strategic business acquisitions in the APAC region for the Company. In his time with McKinsey David was involved in a number of M&A and strategy projects, and established his credentials as a deal maker having conceived and executed a number of acquisitions for AB InBev in China.

 

Brett Crowley

Mr Crowley is a practicing solicitor and a former Partner of Ernst & Young in Hong Kong and Australia, and of KPMG in Hong Kong, and has worked in China establishing and managing JV companies there. Mr Crowley is an experienced chairman, finance director and company secretary of ASX-listed companies, and is a former Senior Legal Member of the NSW Civil and Administrative Tribunal.

Mr Crowley has over 30 years’ experience in advising companies on taxation, corporate strategy, international structuring, capital raising and commercial negotiations.

 

 

BACK TO TOP